HOME >> MEDICINE >> NEWS
2004 Research in Oral Biology Award to Gibson

Honolulu, Hawaii...The 2004 Research in Oral Biology Award will be presented today to Dr. Carolyn Gibson, a faculty member at the University of Pennsylvania School of Dental Medicine since 1986. The award recognizes Dr. Gibson's outstanding contribution to our understanding of the molecular and genetic basis for development of the dentition that has unified clinical observations with fundamental knowledge of gene function.

Dr. Gibson has published widely in a variety of prestigious dental, medical, and scientific journals, including PNAS, Journal of Biological Chemistry, DNA and Cell Biology, and the Journal of Dental Research (JDR), receiving the 2002 AADR William J. Gies Award for best paper (as co-author) in the JDR. She has also long been committed to serving on numerous research review bodies at NIDCR and on international advisory committees.

Dr. Gibson received her award during the Opening Ceremonies of the 82nd General Session of the International Association for Dental Research (IADR), convening at the Hawaii Convention Center. The IADR Research in Oral Biology Distinguished Scientist Award, sponsored since its inception by the Church & Dwight Company, Inc., is designed to recognize outstanding research in the field of oral biology other than in those areas already recognized by specific awards. It is one of 15 Distinguished Scientist Awards bestowed annually by the IADR, representing the Association's highest honor.


'"/>

Contact: Linda Hemphill
Linda@iadr.org
International & American Association for Dental Research
10-Mar-2004


Page: 1

Related medicine news :

1. Researchers search for first sign of congestive heart failure
2. Research offers hope of new treatments for liver damage
3. Research suggests possible blood test for multiple sclerosis
4. Researchers say breast cancer in Africa may provide clues to the disease in African-Americans
5. 2005 Award for Basic Research in Biological Mineralization
6. 2005 Craniofacial Biology Research Award
7. 2005 Research in Dental Caries Award
8. 2005 Research in Prosthodontics and Implants Award
9. 2005 Basic Research in Periodontal Disease Award
10. 2005 Research in Oral Biology Award
11. 2005 Pulp Biology Research Award

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Research Oral Biology Award Gibson

(Date:5/22/2013)... New York (PRWEB) May 22, 2013 Jury ... nation’s first trial involving a da Vinci lawsuit, ... case, the family of a man who allegedly died of ... more than $8 million in damages from Intuitive Surgical, Inc. ... its physician training program for the da Vinci Surgical System ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Nearly 50,000 ... Appeals (BVA) in fiscal year 2012, with even more—54,033—expected ... waiting longer for a decision as the agency reports ... which provides veterans disability appeal services. The ... Veterans Affairs. , Although the BVA received 49,611 cases ...
(Date:5/22/2013)... Ore. A new study shows there is a ... in American young children one that does not ... the United States, girls had higher levels of self-regulation ... control their behavior and impulses, follow directions, and persist ... performance and college completion, in past studies by Oregon ...
(Date:5/22/2013)... Los Angeles, CA (PRWEB) May 22, 2013 ... therapy4parents.com , hosted by Patricia O’Laughlin Psychotherapy in ... now seeing people of all ages as progression ... “Including children of all ages into parenting therapy ... Patricia O’Laughlin emphasizes. Patricia O’Laughlin Psychotherapy now specializes ...
(Date:5/22/2013)... Diversity Focus and Handicap This Productions announce ... promotes awareness that physical disabilities do not stop people ... be held Friday, June 14th at 7:30 p.m. at ... Handicap This! can be purchased at http://www.diversityfocus.org . ... to which their mind is handicap accessible. Mike ...
Breaking Medicine News(10 mins):Health News:Da Vinci Robot Lawsuits: Bernstein Liebhard LLP Notes Beginning of Jury Deliberations in Nation’s First Trial Involving Alleged Da Vinci Surgery Complications 2Health News:Da Vinci Robot Lawsuits: Bernstein Liebhard LLP Notes Beginning of Jury Deliberations in Nation’s First Trial Involving Alleged Da Vinci Surgery Complications 3Health News:Da Vinci Robot Lawsuits: Bernstein Liebhard LLP Notes Beginning of Jury Deliberations in Nation’s First Trial Involving Alleged Da Vinci Surgery Complications 4Health News:Veterans Disability Appeals See Fewer Decisions in FY2012, Reports Allsup 2Health News:'Boys will be boys' in US, but not in Asia 2Health News:'Boys will be boys' in US, but not in Asia 3Health News:Patricia O’Laughlin Psychotherapy of Los Angeles Now Seeing Adults, Teens and Young Children 2Health News:Handicap This! Comes to Marion, Iowa 2
(Date:5/22/2013)... NEW YORK , May 22, 2013  Ohr ... the development of novel therapeutics for unmet medical needs, ... Almenoff , M.D., Ph.D., to its Board of ... industry, working on early and late stage drug development. ... Almenoff join Ohr,s Board," said Dr. Irach Taraporewala, CEO ...
(Date:5/22/2013)... May 22, 2013 Varian Medical Systems ... received 510(k) clearance from the U.S. Food and ... processing workstation that combines radio frequency (RF) and ... Nexus DRF Digital X-Ray Imaging System™ has the ... receptors, including CCD cameras and commercially available flat-panel ...
(Date:5/22/2013)... Ambit Biosciences Corporation (Nasdaq: AMBI ... quizartinib (AC220), a potent and selective FLT3 inhibitor, will ... Society of Clinical Oncology, held May 31 through June ... . Information about the abstracts, ... can be viewed online at http://abstracts2.asco.org/ . Abstract ...
Breaking Medicine Technology:Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors 2Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors 3Varian Medical Systems Receives FDA 510(k) Clearance of its Nexus DRF Digital X-Ray Imaging System 2Ambit Biosciences Announces Presentations of Data from Clinical Investigations of Quizartinib at the Annual Meeting of the American Society of Clinical Oncology 2Ambit Biosciences Announces Presentations of Data from Clinical Investigations of Quizartinib at the Annual Meeting of the American Society of Clinical Oncology 3
Cached News: